Different Clinical Forms of Hereditary Tyrosinemia (Type I) in Patients with Identical Genotypes

This publication has 15 references indexed in Scilit:

• Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
  Nature Genetics, 1996
• FREQUENCY OF THE IVS12+5G→A SPLICE MUTATION OF THE FUMARYLACETOACETATE HYDROLASE GENE IN CARRIERS OF HEREDITARY TYROSINAEMIA IN THE FRENCH CANADIAN POPULATION OF SAGUENAY-LAC-ST-JEAN
  Prenatal Diagnosis, 1996
• Hereditary Tyrosinemia Type I: A New Clinical Classification With Difference in Prognosis on Dietary Treatment
  Hepatology, 1994
• Self-induced correction of the genetic defect in tyrosinemia type I.
  Journal of Clinical Investigation, 1994
• A Single Mutation of the Fumarylacetoacetate Hydrolase Gene in French Canadians with Hereditary Tyrosinemia Type I
  New England Journal of Medicine, 1994
• Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
  Journal of Clinical Investigation, 1993
• Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I
  Human Mutation, 1993
• Localization of cells in the rat brain expressing fumarylacetoacetate hydrolase, the deficient enzyme in hereditary tyrosinemia type 1
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
• Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.
  Journal of Clinical Investigation, 1992
• On the enzymic defects in hereditary tyrosinemia.
  Proceedings of the National Academy of Sciences, 1977